Targeting CD33 for Acute Myeloid Leukemia Therapy

Investigators analyzed the level of CD33 expression in patients with newly diagnosed acute myeloid leukemia and determined its correlation with clinical characteristics. Of the 86 patients, CD33-high was closely related to the patients with normal karyotype, high white blood cell count, and a high ratio of primitive cells.